6th International Conference on Microbiology and Immunology
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th International Conference on Microbiology and Immunology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
6th International Conference on Microbiology and Immunology
Date: October 15–17, 2024
Venue: ExCeL London, London, United Kingdom
Event Type: Academic & Industry Research Conference, Exhibitions, Workshops, Keynote Sessions, Networking Opportunities
Estimated Attendance: 850+ delegates including researchers, academics, industry professionals, and students
Venue: ExCeL London, London, United Kingdom
Event Type: Academic & Industry Research Conference, Exhibitions, Workshops, Keynote Sessions, Networking Opportunities
Estimated Attendance: 850+ delegates including researchers, academics, industry professionals, and students
1. Who Attends (BUYERS / ATTENDEES)
This conference attracts a multidisciplinary audience of research scientists, academic faculty, biotechnology executives, clinical professionals, lab technicians, healthcare providers, and graduate students. Key buyer profiles include:
- Pharmaceutical and biotech companies seeking R&D collaborations
- Lab equipment and diagnostic solution providers
- Recruitment agencies targeting life sciences talent
- Academic institutions building research partnerships
- Government and NGO representatives in public health
2. Location + Attendee Geographic Origin
Event Location: ExCeL London, London, UK – a global hub for scientific conferences.
Attendee Origin:
- 40% Europe (UK, Germany, France, Netherlands)
- 30% North America (USA, Canada)
- 15% Asia-Pacific (Japan, South Korea, India)
- 15% Global (Middle East, Africa, Latin America)
3. Audience Reach
Global Reach: This conference draws international participation through collaborations with organizations like the International Union of Microbiological Societies (IUMS) and the European Federation of Immunological Societies (EFIS).
- 80+ countries represented in past editions
- Keynote speakers from leading global institutions
- Live-streamed sessions for virtual attendees
4. Sample Buyer Company Names + Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | https://www.thermofisher.com | Global Product Manager, Life Sciences | Leading provider of lab equipment and reagents for microbiology research |
| 2 | Merck KGaA (MilliporeSigma) | https://www.merckgroup.com | Director, Life Science Research | Supplies critical materials for immunology and biopharma R&D |
| 3 | Oxford Instruments | https://www.oxford-instruments.com | Business Development Manager, Microscopy | Provides advanced analytical instruments for microbiological analysis |
| 4 | Bio-Rad Laboratories | https://www.bio-rad.com | Sales Director, Clinical Diagnostics | Key player in diagnostic equipment and immunology assays |
| 5 | Danaher Corporation | https://www.danaher.com | Group Product Manager, Life Sciences | Owns multiple brands in lab instrumentation and bioprocessing |
| 6 | Agilent Technologies | https://www.agilent.com | Application Specialist, Genomics | Specializes in analytical chemistry and molecular biology tools |
| 7 | PerkinElmer | https://www.perkinelmer.com | Senior Marketing Manager, Life Sciences | Offers solutions for immunology research and diagnostic testing |
| 8 | Bruker Corporation | https://www.bruker.com | Technical Sales Specialist, Microbiology | Provides mass spectrometry and microbiome analysis systems |
| 9 | Roche Diagnostics | https://www.rochediagnostics.com | Product Manager, Molecular Diagnostics | Global leader in PCR and diagnostic solutions for infectious diseases |
| 10 | Qiagen | https://www.qiagen.com | Business Development Manager, Nucleic Acid Extraction | Specializes in sample preparation for microbiological research |
| 11 | BD (Becton, Dickinson and Company) | https://www.bdzs.com | Sales Director, Clinical Microbiology | Major supplier of diagnostic and research instruments |
| 12 | Thermo Fisher Scientific (UK) | https://www.thermofisher.com/en/home.html | UK Distribution Partner Manager | Regional distribution networks for lab supplies |
| 13 | Shimadzu Corporation | https://www.shimadzu.com | Application Engineer, Chromatography | Provides analytical instruments for microbial metabolite analysis |
| 14 | Illumina, Inc. | https://www.illumina.com | Market Development Manager, Metagenomics | Leader in sequencing technologies for microbiome research |
| 15 | Labcorp Drug Development | https://www.labcorp.com | Director, Microbiology Services | Offers preclinical microbiology and immunology testing services |
5. Job Profiles, Industries & Event Type
Target Job Profiles:
- Research Scientists (Microbiology/Immunology)
- Lab Managers / Technical Directors
- Academic Professors / Department Heads
- Biotech Business Development Managers
- Pharmaceutical R&D Directors
- Clinical Microbiologists / Immunologists
- Product Managers (Lab Equipment/Diagnostics)
- Biotechnology
- Pharmaceuticals
- Academic Research
- Healthcare / Clinical Diagnostics
- Lab Equipment & Software
- Government Health Agencies
6. Estimated Attendance
Expected Footfall: 850+ registered attendees
Breakdown:
- 400+ Academic researchers and students
- 250+ Industry professionals (biotech/pharma)
- 100+ Exhibitor representatives
- 50+ Government and NGO officials
- 50+ Healthcare practitioners
7. Key Focus Areas & Buyer Engagement
Core Themes:
- Advances in Microbial Genomics & Metagenomics
- Immunotherapy and Vaccine Development
- Antimicrobial Resistance (AMR) Research
- Point-of-Care Diagnostics for Infectious Diseases
- Microbiome & Gut Health Innovations
- Biotechnology Applications in Industrial Microbiology
- Exhibit booth for product demonstrations
- Sponsored keynote or workshop sessions
- Targeted delegate bag inserts or digital ads
- Recruitment of speakers or panelists
- Networking lounges and one-on-one meeting rooms
8. Client-Product Fit Analysis
To refine buyer targeting, please share your client’s website. Based on preliminary analysis:
- Lab Equipment Suppliers: Target Thermo Fisher, Merck, BD, and Shimadzu contacts
- Diagnostics Companies: Focus on Bio-Rad, Roche, and Qiagen profiles
- Recruitment Services: Engage academic and industry HR managers
- Software/IT Solutions: Pursue Illumina (bioinformatics) and Agilent (data analysis tools)
- Contract Research Organizations (CROs): Connect with Labcorp and similar entities
9. Industry Recommendations
Based on the client’s product, we recommend prioritizing these industries:
- Biotechnology – For innovation-driven companies
- Pharmaceuticals – For therapeutic and vaccine development
- Healthcare / Clinical Diagnostics – For medical device and diagnostic clients
- Lab Equipment & Software – For instrumentation and digital solutions
Final Recommendation
This conference is highly recommended for B2B outreach, particularly for companies in life sciences, diagnostics, and research instrumentation. The global audience and focus on cutting-edge research create ideal conditions for:
- Product launches and brand visibility
Data sheet
6th International Conference on Microbiology and Immunology – Event Attendee & Buyer Profile Analysis
Event date: 28 October 2026 – 29 October 2026
Location: Dubai, United Arab Emirates
Event status: Upcoming
Research date: 30 June 2026
Event Overview
| Event Name | 6th International Conference on Microbiology and Immunology |
| Event Date | 28 October 2026 – 29 October 2026 |
| Event Status | Upcoming |
| Venue | Dubai venue not publicly confirmed in the material provided |
| City | Dubai |
| State / Region | Dubai |
| Country | United Arab Emirates |
| Organizer | Organizer not publicly confirmed in the material provided |
| Official Event Website | Official current-edition website not publicly verified in the material provided |
| Event Type | Academic & Industry Research Conference, Exhibitions, Workshops, Keynote Sessions, Networking |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Likely international / global scientific audience, subject to official 2026 confirmation |
| Estimated Attendance / Expected Footfall | Historical reference only: 850+ delegates cited in the provided prior description for a 2024 edition. Current 2026 attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Historical / prior-year evidence from user-provided brief; current-year attendance not confirmed |
| Main Purpose of Event | To convene microbiology, immunology, biotechnology, diagnostics, clinical, and public-health stakeholders for research exchange, collaboration, technology showcase, and scientific networking. |
About the Event
The 6th International Conference on Microbiology and Immunology is positioned as a cross-functional scientific and industry event serving microbiology, immunology, clinical diagnostics, biotechnology, pharmaceutical research, and academic collaboration audiences. Based on the event description provided, the format typically combines conference sessions, exhibitions, workshops, keynote presentations, and networking activities, making it relevant for both knowledge exchange and commercial relationship building.
From a lead-generation perspective, the event matters because it brings together research decision-makers, laboratory stakeholders, biotech and pharma professionals, healthcare-linked participants, and institutional representatives who influence equipment selection, research partnerships, diagnostic adoption, clinical collaboration, talent sourcing, and grant or public-health engagement. While current-year organizer, venue, and attendee-list confirmation were not publicly verified in the material provided, the event appears commercially relevant for suppliers targeting life sciences, diagnostics, laboratory technology, scientific services, and research collaboration buyers.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Research scientists and principal investigators | Universities, research institutes, translational medicine centers | Influence lab methods, platform adoption, collaborations, grants, and trial design | High relevance for instruments, reagents, sequencing, assay platforms, CRO services |
| Biotech and pharmaceutical R&D teams | Biotech firms, vaccine developers, therapeutics companies, pharma R&D divisions | Evaluate research tools, biomarker solutions, contract research, diagnostic technologies | Strong commercial value for solution providers seeking enterprise and innovation-led buyers |
| Clinical microbiology and immunology professionals | Hospitals, clinical labs, pathology networks, specialist healthcare providers | Influence diagnostic workflows, test menus, validation, compliance, and procurement specifications | High relevance for diagnostics, lab automation, sample management, infection-control products |
| Laboratory managers and procurement-linked lab operations teams | Academic labs, government labs, commercial testing labs, hospital laboratories | Shortlist suppliers, assess budgets, compare equipment and consumables, support RFQs | Direct buyer relevance for repeat-purchase consumables and capital equipment |
| Public health and government science stakeholders | Health ministries, disease surveillance programs, public health laboratories, regulators | Influence disease monitoring, outbreak preparedness, funding priorities, public procurement | Relevant for surveillance systems, diagnostics, data platforms, training and public-health partnerships |
| Academic institutions and department leadership | Medical schools, life science faculties, postgraduate research departments | Influence research collaboration, faculty partnerships, student pipeline, and grant consortia | Valuable for partnerships, training solutions, publishing, instrumentation, and recruitment |
| Diagnostic and laboratory technology companies | In-vitro diagnostics firms, analyzers, assay developers, lab software companies | Often exhibit, partner, co-develop, or benchmark competitive solutions | Useful for channel partnerships, OEM opportunities, and reseller discussions |
| Graduate students and early-career researchers | Universities, research hospitals, fellowship programs | Limited budget authority but strong future-user influence and technology adoption interest | Best for awareness-building, recruitment, training, and academic program outreach |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Dubai | Host-city academics, healthcare leaders, diagnostics distributors, private healthcare groups, life-science service providers | High | Dubai is a major conference gateway and commercial hub for Middle East scientific events |
| United Arab Emirates | Federal and emirate-level healthcare, university, biotech, laboratory, and hospital stakeholders | High | Likely strong domestic participation due to event location and ease of access |
| GCC / Wider Middle East | Saudi Arabia, Qatar, Oman, Kuwait, Bahrain, Jordan, and regional health or research entities | High | Dubai often attracts regional delegates for life-sciences meetings due to connectivity and visa accessibility |
| Europe | Researchers, biotech firms, academic speakers, and diagnostics companies | Medium to High | Prior event framing suggests strong appeal to international scientific audiences |
| Asia-Pacific | Biotech, pharma, vaccine, and university participants from India, East Asia, and Southeast Asia | Medium | Dubai is a practical connecting point for APAC-to-MENA scientific exchange |
| North America | Academic, biotech, pharma, and research-tool participants | Medium | More likely for speaker, sponsor, partnership, and innovation scouting roles than broad attendance |
| Africa | Public health, infectious disease, and academic institutions | Medium | Potentially relevant because Dubai functions as a transit and regional business hub |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The conference theme, scientific subject matter, and Dubai host location indicate likely global academic and industry appeal. Current 2026 attendee geography is not officially confirmed in the material provided. |
| Regional | Secondary practical reach | Dubai is especially effective for attracting Middle East, GCC, South Asia, and Africa-based participants in healthcare and life sciences. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Mohammed Bin Rashid University of Medicine and Health Sciences | Academic / medical research institution | Relevant for translational medicine, microbiology, immunology, and research collaboration outreach in Dubai | mbru.ac.ae | Dean, Principal Investigator, Research Director, Lab Manager | Strong Market Fit, Attendance Not Confirmed |
| United Arab Emirates University | University / life sciences research | Likely relevant for microbiology, biotechnology, and health sciences collaboration | uaeu.ac.ae | Professor, Research Scientist, Procurement Officer, Lab Director | Strong Market Fit, Attendance Not Confirmed |
| Khalifa University | Research university | Active in biosciences, health research, and advanced scientific infrastructure | ku.ac.ae | Research Chair, Faculty Lead, Scientific Program Director, Purchasing Manager | Strong Market Fit, Attendance Not Confirmed |
| Dubai Health | Healthcare system / public health operator | Relevant for clinical diagnostics, laboratory systems, infection management, and healthcare research | dubaihealth.ae | Lab Director, Clinical Microbiology Head, Procurement Manager, Medical Director | Strong Market Fit, Attendance Not Confirmed |
| Dubai Health Authority | Government healthcare authority | Relevant for public health, diagnostics policy, and healthcare innovation ecosystems | dha.gov.ae | Public Health Director, Procurement Director, Lab Services Lead | Confirmed Government / Procurement Organization |
| Department of Health – Abu Dhabi | Government health authority | Relevant for disease surveillance, health innovation, and public-sector laboratory procurement | doh.gov.ae | Director of Public Health, Procurement Lead, Clinical Lab Manager | Confirmed Government / Procurement Organization |
| Ministry of Health and Prevention UAE | Federal health authority | Relevant for microbiology, immunization, population health, and laboratory policy | mohap.gov.ae | Public Health Official, Procurement Head, Program Director | Confirmed Government / Procurement Organization |
| PureHealth | Healthcare and laboratory ecosystem operator | Relevant for healthcare diagnostics, clinical lab infrastructure, and strategic partnerships | purehealth.ae | Procurement Director, Lab Operations Director, Innovation Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| M42 | Health technology and precision medicine organization | Relevant for genomics, diagnostics, laboratory innovation, and health data partnerships | m42.ae | VP Laboratory Services, Genomics Director, Procurement Manager, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Aster DM Healthcare | Hospital and diagnostics operator | Relevant for clinical microbiology, immunology testing, lab systems, and hospital procurement | asterdmhealthcare.com | Head of Laboratory, Procurement Manager, Medical Director | Strong Market Fit, Attendance Not Confirmed |
Note: No official current-year attendee, exhibitor, sponsor, or speaker organization list was publicly verified in the material provided. Several entries above are prospecting-relevant buyer organizations in the host market, not confirmed attendees.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Research | Research / R&D | Director | Controls scientific budgets, strategic collaborations, and platform selection |
| 2 | Principal Investigator | Research | Senior / Lead | Influences assay choice, project collaboration, and grant-backed purchasing |
| 3 | Laboratory Director | Laboratory Operations | Director | Key decision-maker for diagnostic, instrument, workflow, and compliance purchases |
| 4 | Clinical Microbiology Head | Clinical / Laboratory Services | Head / Director | Directly relevant for testing systems, infection diagnostics, and protocol adoption |
| 5 | Procurement Manager | Procurement / Supply Chain | Manager | Owns vendor onboarding, budget alignment, and procurement process execution |
| 6 | Strategic Sourcing Manager | Sourcing | Manager | Important for recurring consumables, service contracts, and approved supplier frameworks |
| 7 | Medical Director | Clinical Leadership | Director / Executive | Influences clinical use cases, evidence standards, and solution adoption |
| 8 | Partnerships Director | Business Development / Partnerships | Director | Relevant for strategic alliances, co-development, sponsored research, and commercialization |
| 9 | Public Health Program Manager | Government / Public Health | Manager / Director | Key for surveillance tools, disease response systems, and program-based procurement |
| 10 | Head of Innovation / Translational Science | Innovation | Head / Director | Important for new technology pilots and scientific-commercial partnerships |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core fit for immunology, microbiology, assays, vaccine, and platform R&D | R&D collaborations, tools, reagents, instrumentation |
| 2 | Pharmaceuticals | Relevant for immunotherapy, anti-infectives, vaccine, and translational research audiences | Clinical development, lab systems, external research services |
| 3 | Hospital & Health Care | Fits clinical labs, diagnostic operations, and infection-management stakeholders | Clinical diagnostics, workflow systems, consumables, automation |
| 4 | Research | Highly aligned with scientific institutes and non-university research organizations | Research partnerships, instrumentation, funded projects |
| 5 | Higher Education | Universities and medical schools are central attendee and collaboration segments | Lab procurement, grants, training, publishing, partnerships |
| 6 | Medical Devices | Fits diagnostic instrumentation, point-of-care, and laboratory hardware suppliers | Analyzer placement, test systems, clinical validation support |
| 7 | Government Administration | Relevant for ministries, health authorities, and public-sector labs | Public health initiatives, surveillance procurement, policy-driven buying |
| 8 | Information Technology & Services | Supports digital lab platforms, bioinformatics, data integration, and scientific informatics | LIMS, analytics, scientific software, interoperability |
| 9 | Health, Wellness & Fitness | Secondary fit where preventive health, immunology, and wellness-linked diagnostics overlap | Preventive screening and health innovation partnerships |
| 10 | International Trade & Development | Relevant for cross-border scientific cooperation and public-health development organizations | Funding-led health projects and consortium partnerships |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer | Unconfirmed | No official 2026 attendance data verified in available material | Use historical reference only for planning |
| Historical delegate figure | 850+ delegates | Historical / prior-year evidence | User-provided reference description for 2024 edition | Not a confirmed attendee figure for the 2026 Dubai edition |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor directory available in the material provided | Could be modest relative to large-scale trade exhibitions due to scientific conference format |
| Buyer count | Not publicly confirmed | Unconfirmed | No official delegate segmentation verified | Buyer profile is mixed across academic, clinical, and commercial attendees |
| Speaker count | Not publicly confirmed | Unconfirmed | No official agenda or speaker page verified | Potentially a strong source for institution-level targeting once published |
| Sponsor count | Not publicly confirmed | Unconfirmed | No official sponsor page verified | Sponsor organizations may provide partnership and prospecting signals later |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Microbiology research | Improved culture, sequencing, pathogen analysis, and workflow efficiency | Scientific demos, methods discussions, pilot studies | Lab instruments, reagents, sequencing, sample-prep systems |
| Immunology and translational science | Biomarker analysis, immune profiling, assay validation | Co-development and application-specific use-case meetings | Immunoassays, flow systems, bioanalytics, CRO support |
| Clinical diagnostics | Accuracy, turnaround time, regulatory compliance, throughput | Hospital-lab meetings, validation pathways, procurement introductions | IVD systems, automation, consumables, QC platforms |
| Public health and infectious disease response | Surveillance, rapid detection, outbreak preparedness | Government and public-health partnership discussions | Testing networks, surveillance platforms, training and analytics |
| Biotechnology partnerships | Research collaboration, licensing, joint development | Partnering meetings and executive introductions | Platform technologies, specialty services, scientific software |
| Laboratory digitization | Data integrity, sample traceability, workflow automation | IT-lab integration conversations | LIMS, analytics dashboards, integration software, AI-enabled interpretation tools |
| Scientific education and talent development | Training, certification, postgraduate networking, recruitment | Academic partnership and employer-branding outreach | Training content, scientific publishing, recruitment, workshops |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for life sciences, diagnostics, lab technology, scientific services, and collaboration-oriented offerings |
| Decision-maker availability | Medium to High | Scientific and clinical leaders attend such conferences, but many are technical influencers rather than final procurement signatories |
| Data collection potential | Medium | High-quality lead capture is possible through speakers, agenda pages, sponsors, and exhibitor lists once officially published |
| Apollo targeting potential | Very High | The attendee profile maps well to biotech, pharma, hospital, university, and government filters |
| Geographic targeting potential | High | Dubai enables practical segmentation across UAE, GCC, Europe, and Asia-linked scientific clusters |
| Best outreach approach | High | Use value-led outreach focused on research outcomes, lab efficiency, validation support, and collaboration opportunities rather than generic event messaging |
| Overall lead quality | High | Best suited for specialized B2B scientific suppliers and service providers with clear life-science value propositions |
| Best use case | High | Conference-driven prospecting, partnership sourcing, speaker-organization targeting, and targeted attendee-list building once official data is released |
| Limitations / risks | Medium | Current-year official venue, organizer, attendance, and participant lists were not publicly verified in the material provided; technical attendees may outnumber direct buyers |
B2B attendee list building suitability: Suitable, but best results will depend on release of official 2026 speakers, sponsors, agenda, and attendee-facing participation pages.
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Hospital & Health Care; Research; Higher Education; Medical Devices; Government Administration; Information Technology & Services | Capture the most relevant scientific, clinical, and public-sector buyer pools |
| Departments | Research; R&D; Laboratory Operations; Procurement; Supply Chain; Clinical; Innovation; Business Development; Partnerships | Focus on technical and commercial decision-influence layers |
| Seniority | Head; Director; VP; CXO; Manager; Owner where relevant for specialized labs | Prioritize budget owners and strategic influencers |
| Job titles | Laboratory Director, Director of Research, Principal Investigator, Clinical Microbiology Head, Procurement Manager, Strategic Sourcing Manager, Medical Director, Head of Immunology, Scientific Affairs Director, Partnerships Director, Public Health Program Manager, Lab Operations Manager | Create a high-intent scientific and procurement target list |
| Geography | United Arab Emirates; Saudi Arabia; Qatar; Oman; Kuwait; Bahrain; India; United Kingdom; Germany; France; United States | Align with likely event-relevant scientific travel and collaboration corridors |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Balance emerging biotech buyers with enterprise hospitals, universities, and health systems |
| Keywords | microbiology, immunology, diagnostics, clinical laboratory, infectious disease, genomics, sequencing, translational medicine, vaccine, pathogen detection, immunoassay, biosurveillance | Refine toward domain-specialist teams |
| Technologies, if relevant | LIMS, PCR, sequencing, flow cytometry, ELISA, diagnostic analyzers, bioinformatics platforms | Useful for lab-tech, diagnostics, and informatics suppliers |
| Revenue range, if relevant | Prefer mid-market to enterprise for hospital systems, diagnostics firms, and established biotech organizations | Improves commercial qualification for high-value B2B offerings |
| Company type | Public institutions, universities, private hospitals, biotech companies, pharma companies, diagnostics providers | Covers research buyers, clinical buyers, and partnership-led buyers |
Suggested Apollo Search Logic: Target contacts with title keywords such as (“laboratory director” OR “director of research” OR “principal investigator” OR “clinical microbiology” OR “head of immunology” OR “procurement manager” OR “strategic sourcing” OR “medical director” OR “scientific affairs”) AND company keywords such as (“microbiology” OR “immunology” OR “diagnostics” OR “genomics” OR “infectious disease” OR “clinical laboratory” OR “biotechnology”). Prioritize UAE and GCC first, then add Europe and Asia-Pacific scientific clusters for partnership-driven campaigns.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Provided reference description | Event title, Dubai location, UAE country, 28–29 October 2026 dates, historical descriptive context, and prior attendance reference | Medium |
| Mohammed Bin Rashid University of Medicine and Health Sciences | Official organization website | Existence and relevance of a Dubai-based medical research institution for likely buyer profiling | High |
| United Arab Emirates University | Official organization website | Existence and relevance of a UAE university with life-science research potential | High |
| Khalifa University | Official organization website | Existence and relevance of a UAE research university for scientific outreach | High |
| Dubai Health Authority | Official government website | Government health authority relevance for public-health and procurement-side targeting | High |
| Department of Health – Abu Dhabi | Official government website | Public health governance relevance and buyer-side institutional fit | High |
| Ministry of Health and Prevention UAE | Official government website | Federal healthcare and public-health relevance for institutional targeting | High |
| PureHealth | Official organization website | Healthcare and laboratory ecosystem relevance for prospecting | High |
| M42 | Official organization website | Precision medicine, health technology, and diagnostics relevance | High |
| Aster DM Healthcare | Official organization website | Regional hospital and diagnostics operator relevance for buyer profiling | High |
Verification note: Current-year official event organizer, venue, exhibitor list, speaker list, sponsor list, and attendance figures were not publicly verified in the material provided for this analysis. Where event participation could not be confirmed, entries were labeled accordingly and should be treated as prospecting guidance rather than confirmed attendance.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th International Conference on Microbiology and Immunology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds